CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-19 | STUELPNAGEL JOHN R Director | Sale | −1,400 | $175.79 | $246K | 479,591 |
| 2021-01-19 | STUELPNAGEL JOHN R Director | Sale | −900 | $176.57 | $159K | 478,691 |
| 2021-01-19 | STUELPNAGEL JOHN R Director | Sale | −1,110 | $178.31 | $198K | 477,581 |
| 2021-01-19 | STUELPNAGEL JOHN R Director | Sale | −1,608 | $179.28 | $288K | 475,973 |
| 2021-01-19 | STUELPNAGEL JOHN R Director | Sale | −1,206 | $180.27 | $217K | 474,767 |
| 2021-01-19 | STUELPNAGEL JOHN R Director | Sale | −900 | $181.49 | $163K | 473,867 |
| 2021-01-19 | STUELPNAGEL JOHN R Director | Sale | −376 | $182.78 | $69K | 473,491 |
| 2021-01-04 | STUELPNAGEL JOHN R Director | Sale | −1,300 | $138.91 | $181K | 487,191 |
| 2021-01-04 | STUELPNAGEL JOHN R Director | Sale | −5,200 | $139.88 | $727K | 481,991 |
| 2021-01-04 | STUELPNAGEL JOHN R Director | Sale | −900 | $140.94 | $127K | 481,091 |
| 2021-01-04 | STUELPNAGEL JOHN R Director | Sale | −100 | $141.61 | $14K | 480,991 |
| 2021-01-04 | Saxonov Serge Chief Executive Officer | Exercise or conversion | +10,000 | $5.04 | $50K | 890,468 |
| 2021-01-04 | Saxonov Serge Chief Executive Officer | Sale | −2,000 | $139.08 | $278K | 888,468 |
| 2021-01-04 | Saxonov Serge Chief Executive Officer | Sale | −6,277 | $139.91 | $878K | 882,191 |
| 2021-01-04 | Saxonov Serge Chief Executive Officer | Sale | −1,523 | $140.83 | $214K | 880,668 |
| 2021-01-04 | Saxonov Serge Chief Executive Officer | Sale | −200 | $141.91 | $28K | 880,468 |
| 2021-01-04 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −10,000 | 114,515 | ||
| 2021-01-04 | McAnear Justin J. Chief Financial Officer | Exercise or conversion | +10,000 | $5.04 | $50K | 30,774 |
| 2021-01-04 | McAnear Justin J. Chief Financial Officer | Sale | −2,000 | $139.08 | $278K | 28,774 |
| 2021-01-04 | McAnear Justin J. Chief Financial Officer | Sale | −6,036 | $139.91 | $845K | 22,738 |
Page 49 of 57 · 1,128 trades